Molecular Biology Enzymes Market: Major Revenue Surge in Predicted by 2026

Posted March 28, 2024 by mmvaidya01

Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Overview of This Study:

In order to estimate the current size of the molecular biology enzymes and kits & reagents market, this study covered four main tasks. A thorough investigation was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The following stage involved conducting primary research to confirm these conclusions, hypotheses, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. The market size of the various segments and subsegments was then estimated using data triangulation techniques and market breakdown.

Major Growth Driving Factors:

Increased R&D spending and research efforts in the life science sector, an increase in genome projects, technical developments in the life science sector, and an increase in the prevalence of genetic disorders are some of the reasons propelling the global market's growth. However, over the projected time, it is anticipated that the market's expansion will be constrained by the small reimbursements for genetic testing.

Download PDF Brochure@

Global Industry Segmentation:

The molecular biology enzymes and kits & reagents market was led by the kits & reagents segment in terms of product segment share in 2020.

The molecular biology enzymes and kits & reagents market is divided into two segments based on products: enzymes and kits & reagents. In 2020, the kits and reagents segment held the greatest proportion of the global market for molecular biology enzymes and kits and reagents, with 85.9%. The main reason for this segment's huge share is because consumers frequently buy these single-use products. This area is anticipated to develop at the fastest rate due to the extensive use of it by biotechnology and pharmaceutical firms.

In 2020, the molecular biology enzymes and kits & reagents market's application segment, which included polymerase chain reaction (PCR), held the greatest share.

The polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection) are the segments of the global molecular biology enzymes and kits & reagents market based on applications. The majority of end users use PCR equipment extensively, and PCR is increasingly being used for molecular diagnostic assays in hospitals and clinics. These factors combined to give the polymerase chain reaction (PCR) segment the largest share of the molecular biology enzymes and kits & reagents market in 2020—28.3%.

Geographical Growth Scenario:

The Asia Pacific region is the fastest-growing region of the molecular biology enzymes and kits & reagents market in 2020.

The market in the APAC is expected to grow at the highest rate during the forecast period. Growth in the APAC market is driven by increasing government interest in the biomedical & biotechnology industries, the presence of bio-clusters in India and China, and the growing outsourcing of clinical research activities to Asian countries.

Request Sample Pages@

Global Key Players:

The global molecular biology enzymes and kits & reagents market is highly consolidated. Key players in the molecular biology enzymes and kits & reagents market include Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), Molecular Biology Resources (US), Bio-Rad Laboratories, Inc. (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Country United States
Categories Biotech , Industry , News
Tags molecular biology enzymes market , molecular biology enzymes , molecular biology
Last Updated March 28, 2024